Drugs / PSMA-targeted CAR-T cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05354375 | Dec 2022 → Nov 2025 overdue | — | The Affiliated Hospital of Xuzhou Medical University | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PSMA-targeted CAR-T cells | “Clinical Study of PSMA-targeted CAR-T Cells in the Treatment of Castration-resistant Prostate Cancer” NCT05354375 ↗ |
| Modality | Cell therapy | “CAR-T cell immunotherapy” NCT05354375 ↗ |